Doctor Directory

Madan H. Jagasia, MD, MBBS, MS, MMHC

  • Chief Medical Officer, Vanderbilt-Ingram Cancer Center
  • Executive Medical Director, Cancer PCC
  • Co-Leader, Translational Research and Interventional Oncology, VICC
  • Professor of Medicine
  • Professor of Medicine

Areas of Expertise

  • Bone Marrow Transplant
  • Cancer
  • Hematologic Cancer
  • Hematology
  • Hematology/Oncology
  • Leukemia, Acute and Chronic
  • Lymphoma, Low, Intermediate, and High Grade
  • Stem Cell Transplant

Board Certifications

  • Hematology - American Board of Internal Medicine, 2002


  • Bachelor of Medicine, Bachelor of Surgery - King Edward Memorial College, 1992
  • Internship - King Edward Memorial Hospital, 1993
  • Internship - Nassau County Medical Center, 1994
  • Residency - University of Tennessee Health Science Center, 1996
  • Residency - Methodist Hospital, 1996
  • Fellowship - Vanderbilt University Medical Center, 2001
  • Masters of Science, 2006
  • Management in Health Care - Vanderbilt University Owen Graduate School of Management, 2017
  • Doctor of Medicine


1301 Medical Center Drive, Suite 3903
Nashville, TN 37232

Patient Comments

Patient Comments are gathered from the Press Ganey Patient Satisfaction Survey and displayed in full. Patients are not identified in order to respect patient privacy.
  • At a time of utmost stress, Dr Jagasia and the entire staff at Vanderbilt bring a sense of calm, caring and peace. Dr. Madan Jagasia went above and beyond the norm to give us all the information needed to make a decision on how to proceed. Dr Jagasia's knowledge and "bedside" manner is incredible. We were in awe.
    Patient | August 27, 2019
  • Good.
    Patient | June 24, 2019
  • *Dr. Jagasia is an excellent physician I consider myself blessed to have him as a physician.
    Patient | June 10, 2019
  • Good _____ & inspires confidence.
    Patient | June 7, 2019
  • Friendly and willingness to answer any question I mite have. I don't feel he is hurry me at all. Always very helpful. Great person. Wish we had more like him. One of a kind.
    Patient | May 28, 2019